In the video, Mary Relling provides an introduction to pharmacogenetics and the PG4KDS project, and then the group discuss important issues including:
- can genetic variants that give information about drug response be separated from those that give information about disease risk?
- why are genetic tests different from other clinical tests?
- the advantages and disadvantages of placing genetic results in the medical record